Researcher

Hong Huang

Shantou Central Hospital

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 30, 2026 · JOURNAL ARTICLE

Recent Advances in Non-Viral Vectors for Gene Therapy and Gene Delivery: From Lipid Nanoparticles to Engineered Extracellular Vesicles

Pharmaceutics

This is a narrative review summarizing the state of non-viral gene delivery platforms, their clinical maturity, barriers, and future directions for researchers and clinicians.

Expert GuidanceYongfeng Yang Extracellular Vesicles in Disease Yi Li

AUG 18, 2026 · JOURNAL ARTICLE

Differences in adverse drug reactions between GnRH antagonists and agonists in the treatment of prostate cancer: a retrospective analysis using real-world data

Frontiers in Pharmacology

Pharmacovigilance analysis of 2,486 real-world adverse event reports confirming known safety differences between drug classes with clear disproportionality signals, but observational and hypothesis-generating rather than practice-changing in design.

Important Confirmatory EvidenceProstate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Yingxun Luo

Reported

Total reports analysed2,486

GnRH antagonist reports444

GnRH agonist reports2,042